|Deramciclane||Dermostatin||Derris Root||D-Erythrose||D-Erythrose 4-Phosphate|
|Systematic (IUPAC) name|
|Legal status||veterinary prescription only|
|Protein binding||high (more than 90%)|
|Half-life||3 hours at 2–3 mg/kg|
|(what is this?)|
Deracoxib (trade name Deramaxx, Novartis) is a non-steroidal anti-inflammatory drug of the coxib class, used in veterinary medicine to treat osteoarthritis in dogs. It is sold in tablets, which have added beefy flavor to increase palatability. Deramaxx received FDA approval in August 2002 for "the control of post operative pain and inflammation associated with orthopedic surgery in dogs."